Settlement Structure: Claims Made
Active: OpenCase Summary:
Celgene is settling, for the second time, an antitrust class action alleging that it took action to prevent or delay the entry of cheaper generics to the market. The complaint alleged that consumers and third-party payors were forced to pay higher prices for than they would have had generics been available.
Celgene was able to rescind a 2019 settlement when a number of entities opted out. This is a new settlement designed to replace the earlier one.Docket Number:
Company: Celgene Corporation
Filing Deadline: October 15, 2020
Objection Deadline: September 15, 2020
Exclusion Deadline: September 15, 2020
Final Approval Hearing: September 30, 2020Proof of Purchase:
If you submitted a claim form for the previous settlement, you do not have to submit another one. However, you might want to submit a Supplemental Claim Form as an update.Eligibility:
You may be eligible if you paid for thalomid or revlimid as a consumer or third-party payor (such as a health benefit plan) in California, the District of Columbia, Florida, Kansas, Maine, Massachusetts, Michigan, Nebraska, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, or Tennessee, at any time before May 20, 2020.
If you submitted a claim form for the previous settlement, you do not need to submit another. However, you might want to submit a Supplemental Claim Form.
For further information, see the Excluded Entity List or the Notice at http://www.thalomidrevlimidlitigation.com/media/2849311/consumer_notice.pdf.Typical Settlement Amount:
Share of the net settlement fund. Amounts will depend on the amount of money spent by each class member on purchases of the drugs and the total amount spent by all class members.
Total Settlement Amount: $34 millionClass Representative Proposed Incentive Fee:
Block & Leviton LLP
Hach Rose Schirripa & Cheverie LLP
Case Name: In re Thalomid and Revlimid Antitrust Litigation
Settlement Website: Thalomid and Revlimid Antitrust Settlement Website
KCC Class Action Services, LLC
In re Thalomid and Revlimid Antitrust Litigation
c/o KCC Class Action Services LLC
P.O. Box 43508
Providence, RI 02940-3508